Bin Li

Bin Li

Auto-generated profile, based on publicly available information

Bin Li

MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Cell Reports
Verified
Journal Article
Open access
ZWZe-Lin Wang
Ze-Lin Wang
BLBin Li
Bin Li
YLYu-Xia Luo
Yu-Xia Luo
QLQiao Lin
Qiao Lin
SLShu-Rong Liu
Shu-Rong Liu
LQLiang-Hu Qu
Liang-Hu Qu
RNA-binding proteins (RBPs) regulate the expression of thousands of transcripts, and some are reported to be involved in human tumorigenesis. However, little is known about the dysregulation of RBPs at the genomic level in human cancers. Here, we conducted comprehensive analyses for expression, somatic copy number alteration (SCNA), and mutation profiles of 1,542 RBPs in ∼7,000 clinical specimens across 15 cancer types. We identified markedly dysregulated RBPs and found that downregulation was a predominant pattern in cancer. Combined with recurrent SCNA data, we identified 76 RBPs as potential drivers. We also discovered a set of 139 RBPs that were significantly mutated in cancers. We confirmed the oncogenic property of six RBPs in colorectal and liver cancer cell lines by using in vitro functional experiments. Our study highlights the potential roles of RBPs in carcinogenesis and lays the groundwork to better understand the functions and mechanisms of RBPs in cancer.

18 November 2022 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JHJunhong Huang
Junhong Huang
WZWujian Zheng
Wujian Zheng
PZPing Zhang
Ping Zhang
QLQiao Lin
Qiao Lin
ZCZhirong Chen
Zhirong Chen
JYJian-Hua Yang
Jian-Hua Yang
Non-coding RNAs (ncRNAs) are emerging as key regulators of various biological processes. Although thousands of ncRNAs have been discovered, the transcriptional mechanisms and networks of the majority of ncRNAs have not been fully investigated. In this study, we updated ChIPBase to version 3.0 (https://rnasysu.com/chipbase3/) to provide the most comprehensive transcriptional regulation atlas of ncRNAs and protein-coding genes (PCGs). ChIPBase has identified ∼151 187 000 regulatory relationships between ∼171 600 genes and ∼3000 regulators by analyzing ∼55 000 ChIP-seq datasets, which represent a 30-fold expansion. Moreover, we de novo identified ∼29 000 motif matrices of transcription factors. In addition, we constructed a novel ‘Enhancer’ module to predict ∼1 837 200 regulation regions functioning as poised, active or super enhancers under ∼1300 conditions. Importantly, we constructed exhaustive coexpression maps between regulators and their target genes by integrating expression profiles of ∼65 000 normal and ∼15 000 tumor samples. We built a ‘Disease’ module to obtain an atlas of the disease-associated variations in the regulation regions of genes. We also constructed an ‘EpiInter’ module to explore potential interactions between epitranscriptome and epigenome. Finally, we designed ‘Network’ module to provide extensive and gene-centred regulatory networks. ChIPBase will serve as a useful resource to facilitate integrative explorations and expand our understanding of transcriptional regulation.

13 November 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JXJiajia Xuan
Jiajia Xuan
LCLifan Chen
Lifan Chen
ZCZhirong Chen
Zhirong Chen
JPJunjie Pang
Junjie Pang
JHJunhong Huang
Junhong Huang
JYJian-Hua Yang
Jian-Hua Yang
Although over 170 chemical modifications have been identified, their prevalence, mechanism and function remain largely unknown. To enable integrated analysis of diverse RNA modification profiles, we have developed RMBase v3.0 (http://bioinformaticsscience.cn/rmbase/), a comprehensive platform consisting of eight modules. These modules facilitate the exploration of transcriptome-wide landscape, biogenesis, interactome and functions of RNA modifications. By mining thousands of epitranscriptome datasets with novel pipelines, the ‘RNA Modifications’ module reveals the map of 73 RNA modifications of 62 species. the ‘Genes’ module allows to retrieve RNA modification profiles and clusters by gene and transcript. The ‘Mechanisms’ module explores 23 382 enzyme-catalyzed or snoRNA-guided modified sites to elucidate their biogenesis mechanisms. The ‘Co-localization’ module systematically formulates potential correlations between 14 histone modifications and 6 RNA modifications in various cell-lines. The ‘RMP’ module investigates the differential expression profiles of 146 RNA-modifying proteins (RMPs) in 18 types of cancers. The ‘Interactome’ integrates the interactional relationships between 73 RNA modifications with RBP binding events, miRNA targets and SNPs. The ‘Motif’ illuminates the enriched motifs for 11 types of RNA modifications identified from epitranscriptome datasets. The ‘Tools’ introduces a novel web-based ‘modGeneTool’ for annotating modifications. Overall, RMBase v3.0 provides various resources and tools for studying RNA modifications.

7 June 2016 in Oncotarget
Verified
Journal Article
Open access
YGYan-Hua Guo
Yan-Hua Guo
LWLu-Qin Wang
Lu-Qin Wang
BLBin Li
Bin Li
HXHui Xu
Hui Xu
JYJian-Hua Yang
Jian-Hua Yang
LQLiang-Hu Qu
Liang-Hu Qu
Wnt/-catenin pathway transactivates microRNA-150 that promotes EMT of colorectal cancer cells by suppressing CREB signaling

1 September 2018 in Molecular Oncology
Verified
Journal Article
Open access
PDF file
LWLu‐Qin Wang
Lu‐Qin Wang
PYPeng Yu
Peng Yu
BLBin Li
Bin Li
YGYan‐Hua Guo
Yan‐Hua Guo
ZLZi‐Rui Liang
Zi‐Rui Liang
LQLiang-Hu Qu
Liang-Hu Qu
MiR‐372/373, a cluster of stem cell‐specific microRNAs transactivated by the Wnt pathway, has been reported to be dysregulated in various cancers, particularly colorectal cancer (CRC); however, the unique role of these microRNAs in cancer remains to be discovered. In the present study, we characterized the upregulation in expression of miR‐372/373 in CRC tissues from The Cancer Genome Atlas data, and then showed that overexpression of miR‐372/373 enhanced the stemness of CRC cells by enriching the CD26/CD24‐positive cell population and promoting self‐renewal, chemotherapy resistance and the invasive potential of CRC cells. To clarify the mechanism underlying microRNA‐induced stemness, we profiled 45 cell signaling pathways in CRC cells overexpressing miR‐372/373 and found that stemness‐related pathways, such as Nanog and Hedgehog, were upregulated. Instead, differentiation‐related pathways, such as NFκB, MAPK/Erk and VDR, were markedly repressed by miR‐372/373. Numerous new targets of miR‐372/373 were identified, including SPOP, VDR and SETD7, all of which are factors important for cell differentiation. Furthermore, in contrast to the increase in miR‐372/373 expression in CRC tissues, the expression levels of SPOP and VDR mRNA were significantly downregulated in these tissues, indicative of the poor differentiation status of CRC. Taken together, our findings suggest that miR‐372/373 enhance CRC cell stemness by repressing the expression of differentiation genes. These results provide new insights for understanding the function and mechanisms of stem cell‐specific microRNAs in the development of metastasis and drug resistance in CRC.

21 November 2022 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
HLHao-Tian Lei
Hao-Tian Lei
ZWZhang-Hao Wang
Zhang-Hao Wang
BLBin Li
Bin Li
YSYang Sun
Yang Sun
SMShi-Qiang Mei
Shi-Qiang Mei
Lingling ZhengLingling Zheng
Lingling Zheng
TRNA molecules contain dense, abundant modifications that affect tRNA structure, stability, mRNA decoding and tsRNA formation. tRNA modifications and related enzymes are responsive to environmental cues and are associated with a range of physiological and pathological processes. However, there is a lack of resources that can be used to mine and analyse these dynamically changing tRNA modifications. In this study, we established tModBase (https://www.tmodbase.com/) for deciphering the landscape of tRNA modification profiles from epitranscriptome data. We analysed 103 datasets generated with second- and third-generation sequencing technologies and illustrated the misincorporation and termination signals of tRNA modification sites in ten species. We thus systematically demonstrate the modification profiles across different tissues/cell lines and summarize the characteristics of tRNA-associated human diseases. By integrating transcriptome data from 32 cancers, we developed novel tools for analysing the relationships between tRNA modifications and RNA modification enzymes, the expression of 1442 tRNA-derived small RNAs (tsRNAs), and 654 DNA variations. Our database will provide new insights into the features of tRNA modifications and the biological pathways in which they participate.